Literature DB >> 20957749

HPK1 competes with ADAP for SLP-76 binding and via Rap1 negatively affects T-cell adhesion.

Irene M Patzak1, Sebastian Königsberger, Akira Suzuki, Tak W Mak, Friedemann Kiefer.   

Abstract

The hematopoietic progenitor kinase 1 (HPK1) signals into MAPK and NFκB pathways downstream of immunoreceptors, but enigmatically is a negative regulator of leukocytes. Here, we report a novel role for HPK1 in regulating the activation of the adhesion molecule leukocyte function-associated antigen-1 (LFA-1). Upon TCR stimulation, mediated by binding of adhesion and degranulation promoting adaptor protein (ADAP) to SLP-76, a ternary complex composed of ADAP/55-kDa src kinase associated phosphoprotein (SKAP-55) and RIAM translocates to the membrane and causes membrane recruitment of the active small GTPase Ras-related protein 1 (Rap1). Active Rap1, via its binding to RapL (regulator for cell adhesion and polarization enriched in lymphoid tissues), mediates LFA-1 integrin activation. We show here that HPK1, which also binds SLP-76, compete with ADAP for SLP-76 binding. In addition, HPK1 dampens Rap1 activation, resulting in decreased LFA-1 activity. Analysis of HPK1-deficient T cells revealed increased ADAP recruitment to SLP-76 and elevated Rap1 activation in those cells, leading to increased adhesion to ICAM-1 and cell spreading. Altogether, these results describe a novel function for HPK1 in linking TCR signaling to cell adhesion regulation and provide a mechanistic explanation for the negative regulatory role of HPK1 in T-cell biology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20957749     DOI: 10.1002/eji.201040313

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

Review 1.  Germinal center kinases in immune regulation.

Authors:  Hailei Yin; Zhubing Shi; Shi Jiao; Cuicui Chen; Wenjia Wang; Mark I Greene; Zhaocai Zhou
Journal:  Cell Mol Immunol       Date:  2012-09-10       Impact factor: 11.530

2.  Slp-76 is a critical determinant of NK-cell mediated recognition of missing-self targets.

Authors:  Kristin Lampe; Mehari Endale; Siobhan Cashman; Hao Fang; Jochen Mattner; David Hildeman; Kasper Hoebe
Journal:  Eur J Immunol       Date:  2015-05-22       Impact factor: 5.532

Review 3.  Novel classes of immunotherapy for breast cancer.

Authors:  Alberto Hernando-Calvo; David W Cescon; Philippe L Bedard
Journal:  Breast Cancer Res Treat       Date:  2021-10-08       Impact factor: 4.872

4.  ADAP is an upstream regulator that precedes SLP-76 at sites of TCR engagement and stabilizes signaling microclusters.

Authors:  Juliana B Lewis; Frank A Scangarello; Joanne M Murphy; Keith P Eidell; Michelle O Sodipo; Michael J Ophir; Ryan Sargeant; Maria-Cristina Seminario; Stephen C Bunnell
Journal:  J Cell Sci       Date:  2018-11-08       Impact factor: 5.285

5.  HPK1 positive expression associated with longer overall survival in patients with estrogen receptor-positive invasive ductal carcinoma‑not otherwise specified.

Authors:  Jiaojiao Wang; Lijie Song; Sen Yang; Weijie Zhang; Pengwei Lu; Shenglei Li; Huixiang Li; Liuxing Wang
Journal:  Mol Med Rep       Date:  2017-08-02       Impact factor: 2.952

Review 6.  A perspective on HPK1 as a novel immuno-oncology drug target.

Authors:  Sansana Sawasdikosol; Steven Burakoff
Journal:  Elife       Date:  2020-09-08       Impact factor: 8.140

7.  Prognostic Value of mRNA Expression of MAP4K Family in Acute Myeloid Leukemia.

Authors:  Zhenjie Bai; Qingmei Yao; Zhongyi Sun; Fang Xu; Jicheng Zhou
Journal:  Technol Cancer Res Treat       Date:  2019-01-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.